DEAR DR. ROACH: I am a 74-year-old woman in good health. I was diagnosed with pyoderma gangrenosum on my left leg. I was in a lot of pain. Can you tell me the cause of this rare disease? Also, is ...

Please provide your email address to receive an email when new articles are posted on . A minimal important difference of 7-day pain scores was a 2-point improvement on an 11-point scale. A 2-point ...

Vilobelimab is a first-in-class anti-human complement factor C5a monoclonal antibody. The Food and Drug Administration (FDA) has granted Fast Track designation to vilobelimab for the treatment of ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Ulcerative pyoderma gangrenosum is a rare disease with ...

A 32-year-old British man says he feels like a “zombie” due to a rare condition that causes painful, pus-filled sores to form on his face and various parts of his body. Steve Young, of Devon, was ...

In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dear Dr. Roach • I am a 74-year-old woman in good health. I was diagnosed with pyoderma gangrenosum on my left leg. I was in a ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...